Outcome of patients with Hodgkin's disease failing after primary MOPP- ABVD

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 528-534

  Bonfante, V ^a   Santoro, A ^a   Viviani, S ^a   Devizzi, L ^a   Balzarotti, M ^a   Soncini, F ^a   Zanini, M ^a   Valagussa, P ^a   Bonadonna, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; PREDNIMUSTINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER; TREATMENT OUTCOME;

EID: 0031033626     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.528     Document Type: Article

References (30)

1. De Vita VT Jr, Simon RM, Hubbard SM, et al.: Curability of advanced Hodgkin's disease with chemotherapy. Ann Intern Med 92:587-595, 1980
2. Bonadonna G, Valagussa P, Santoro A: Alternating non-cross resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Ann Intern Med 104:739-746, 1986
3. Santoro A, Bonadonna G, Valagussa P, et al.: Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease. Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5:27-37, 1987
4. Canellos GP, Anderson JR, Kathleen JP, et al.: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
5. Fisher RI, De Vita VT, Hubbard SP, et al.: Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med 90:761-763, 1979
6. Viviani S, Santoro A, Negretti E, et al.: Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. Ann Oncol 1:123-127, 1990
7. Salvagno L, Sorarù M, Aversa SML, et al.: Late relapses in Hodgkin's disease: Outcome of patients relapsing more than twelve months after primary chemotherapy. Ann Oncol 4:657-662, 1993
8. Longo DL, Duffley PL, Young RC, et al.: Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability of cure. J Clin Oncol 10:210-218, 1992
9. Canellos GP: Is there an effective salvage therapy for advanced Hodgkin's disease? Ann Oncol 2:1-7, 1991
10. Santoro A, Bonfante V, Bonadonna G: Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med 96:139-143, 1982
11. Buzaid AC, Lippman SM, Miller TP: Salvage therapy of advanced Hodgkin's disease. Am J Med 83:523-532, 1987
12. Viviani S, Bonadonna G, Santoro A, et al.: Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: 10-year results. J Clin Oncol 14:1421-1430, 1996
13. Santoro A, Viviani S, Valagussa P, et al.: CCNU, etoposide and prednimustine in refractory Hodgkin's disease. Semin Oncol 13:23-26, 1986
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Peto R, Peto J: Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 135:185-206, 1972
16. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
17. Miller RC: Survival Analysis. New York, NY, Wiley, 1981
18. Lohri A, Barnett M, Fairey RN, et al.: Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: Identification of risk factors from the British Columbia experience 1970 to 1988. Blood 77:2292-2298, 1991
19. Desch CE, Lasaka MR, Smith TJ, et al.: The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. J Clin Oncol 10:200-209, 1992
20. Champlin R: Bone marrow transplantation for Hodgkin's disease. Recent advances and current issues. Leuk Lymphoma 10:103-108, 1993 (suppl)
21. Goldstone AH, McMillan AK: The place of high-dose therapy with hemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease. Ann Oncol 4:21-27, 1993 (suppl 1)
22. Gianni AM, Siena S, Bregni M, et al.: High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease. A 6-year update. Ann Oncol 4:889-891, 1993
23. Armitage JO, Bierman PJ, Vose JM, et al.: Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med 91:605-611, 1991
24. Coiffier B, Philip T, Burnett AK, et al.: Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies. J Clin Oncol 12:226-231, 1994
25. Linch DC, Winfield D, Goldstone AH, et al.: Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomized trial. Lancet 341:1051-1054, 1993
26. Velasquez WS, Cabanillas F, Salvador P, et al.: Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and desamethasone (DHAP). Blood 71:117-122, 1988
27. Fermé C, Bastion Y, Lepage E, et al.: The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease. Ann Oncol 6:543-549, 1995
28. Reece DE, Connors JM, Spinelli JJ, et al.: Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 83:1193-1199, 1994
29. Valagussa P, Bonadonna G: Carcinogenic effects of Cancer Treatment, in Peckham M, Pinedo H, Veronesi U (eds): Oxford Textbook of Oncology. Oxford, United Kingdom, Oxford University, 1995, pp 2348-2358
30. Bookman MA, Longo DL: Concomitant illness in patients treated for Hodgkin's disease. Cancer Treat Rev 13:77-111, 1986